0.7708

2.31% -0.0182

After Hours: .76 -0.0108 -1.40%

Pasithea Therapeutics Corp (KTTA)

Overview News Price History Financials Discussions Forecast

Pasithea Therapeutics Corp stock is traded at $0.7708, with a volume of 52,556. It is down -2.31% in the last 24 hours and up +10.11% over the past month. Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Previous Close:

$0.789

Open:

$0.8

24h Volume:

52,556

Relative Volume:

0.39

Market Cap:

$5.74M

Revenue:

Net Income/Loss:

$-16.28M

P/E Ratio:

-0.0554

EPS:

-13.91

Net Cash Flow:

$-13.75M

1W Performance:

-2.46%

1M Performance:

+10.11%

6M Performance:

-25.17%

1Y Performance:

-80.46%

1-Day Range:

$0.7635

$0.8001

1-Week Range:

$0.7444

$0.807

52-Week Range:

$0.65

$7.50

Pasithea Therapeutics Corp Stock (KTTA) Company Profile

Name

Pasithea Therapeutics Corp

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

(702) 514-4174

Address

1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH

Employee

Twitter

Next Earnings Date

2024-08-11

Latest SEC Filings

KTTA's Discussions on Twitter

Compare KTTA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KTTA Pasithea Therapeutics Corp	0.7708	5.82M	0	-16.28M	-13.75M	-13.91
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Pasithea Therapeutics Corp (KTTA)

Pasithea Therapeutics Corp Stock (KTTA) Company Profile

Compare KTTA with other stocks

Pasithea Therapeutics Corp Stock (KTTA) Latest News

Real time alert setup for Pasithea Therapeutics Corp. performanceJuly 2025 Action & AI Enhanced Trading Signals - Newser

How to interpret RSI for Pasithea Therapeutics Corp. Equity Warrant stockJuly 2025 Gainers & Stepwise Trade Signal Implementation - Newser

Is Pasithea Therapeutics Corp. trending in predictive chart modelsPortfolio Gains Summary & AI Optimized Trading Strategy Guides - Newser

Using Ichimoku Cloud for Pasithea Therapeutics Corp. Equity Warrant technicalsMarket Performance Recap & Weekly Return Optimization Alerts - Newser

Volume spikes in Pasithea Therapeutics Corp. stock – what they mean2025 Top Gainers & Risk Managed Trade Strategies - Newser

Pasithea Therapeutics Corp. stock prediction for this weekGap Up & Reliable Entry Point Trade Alerts - Newser

Signal strength of Pasithea Therapeutics Corp. stock in tech scannersJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser

Visual analytics tools that track Pasithea Therapeutics Corp. Equity Warrant performanceRisk Management & Real-Time Chart Breakout Alerts - Newser

Using fundamentals and technicals on Pasithea Therapeutics Corp. Equity WarrantStock Surge & Free Safe Entry Trade Signal Reports - Newser

Pasithea Therapeutics Corp. stock outlook for YEARPortfolio Risk Summary & Real-Time Chart Pattern Alerts - Newser

Will Pasithea Therapeutics Corp. Equity Warrant outperform the market2025 Technical Overview & Stepwise Trade Execution Plans - Newser

Will Pasithea Therapeutics Corp. Equity Warrant stock recover after recent dropWeekly Trend Summary & Long Hold Capital Preservation Tips - Newser

Can volume confirm reversal in Pasithea Therapeutics Corp. Equity Warrant2025 Institutional Moves & Weekly Watchlist for Consistent Profits - Newser

What the charts say about Pasithea Therapeutics Corp. todayFed Meeting & Fast Gain Stock Tips - Newser

is pasithea therapeutics corp. equity warrant stock poised for growth2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser

Will Pasithea Therapeutics Corp. Equity Warrant rebound enough to break evenJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - Newser

Can volume confirm reversal in Pasithea Therapeutics Corp.Recession Risk & Safe Entry Point Identification - Newser

How to escape a deep drawdown in Pasithea Therapeutics Corp.Quarterly Profit Review & Daily Oversold Bounce Ideas - Newser

What Fibonacci levels say about Pasithea Therapeutics Corp. Equity Warrant reboundWeekly Risk Report & AI Powered Buy and Sell Recommendations - Newser

Relative strength of Pasithea Therapeutics Corp. in sector analysisTrade Ideas & High Accuracy Swing Entry Alerts - Newser

Applying Wyckoff theory to Pasithea Therapeutics Corp. Equity Warrant stock2025 AllTime Highs & Technical Confirmation Alerts - Newser

Price momentum metrics for Pasithea Therapeutics Corp. Equity Warrant explained2025 Key Lessons & Step-by-Step Trade Execution Guides - Newser

Will Pasithea Therapeutics Corp. bounce back from current supportWeekly Trade Review & Real-Time Buy Signal Notifications - Newser

Chart overlay techniques for tracking Pasithea Therapeutics Corp. Equity Warrant2025 Top Decliners & Technical Entry and Exit Alerts - Newser

What indicators show strength in Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - Newser

Is Pasithea Therapeutics Corp. Equity Warrant stock poised for growth2025 Analyst Calls & Consistent Profit Trading Strategies - Newser

Will Pasithea Therapeutics Corp. see short term momentumSell Signal & Verified Short-Term Trading Plans - Newser

Market reaction to Pasithea Therapeutics Corp. Equity Warrant’s recent news - Newser

Pasithea Therapeutics Corp. Equity Warrant stock outlook for YEARJuly 2025 Highlights & Consistent Growth Stock Picks - Newser

Using Python tools to backtest Pasithea Therapeutics Corp. Equity Warrant strategiesRate Hike & Weekly Watchlist of Top Performers - Newser

What’s next for Pasithea Therapeutics Corp. stock priceQuarterly Profit Review & Community Consensus Trade Signals - Newser

Pasithea Therapeutics Approves Key Proposals at Annual Meeting - MSN

Pasithea Therapeutics (NASDAQ:KTTA) Stock Price Up 3% – Here’s Why - Defense World

What’s the recovery path for long term holders of Pasithea Therapeutics Corp. Equity WarrantTrade Exit Report & Low Drawdown Trading Strategies - Newser

Is Pasithea Therapeutics Corp. Equity Warrant stock entering bullish territoryTreasury Yields & AI Powered Market Entry Ideas - Newser

Heatmap analysis for Pasithea Therapeutics Corp. Equity Warrant and competitorsStop Loss & High Accuracy Trade Signal Alerts - Newser

Published on: 2025-09-10 01:06:06 - Newser

Pasithea Therapeutics Corp. stock volume spike explainedJuly 2025 Rallies & Daily Price Action Insights - Newser

Heatmap analysis for Pasithea Therapeutics Corp. and competitors - Newser

Key resistance and support levels for Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Closing Moves & Safe Capital Growth Stock Tips - Newser

How to use a screener to detect Pasithea Therapeutics Corp. Equity Warrant breakoutsMarket Performance Report & Free Safe Entry Trade Signal Reports - Newser

Pasithea Therapeutics Corp Stock (KTTA) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to KTTA